FOR IMMEDIATE RELEASE
JFC TECHNOLOGIES, CHINA TO BECOME PART OF AMERIGEN PHARMACEUTICALS
(Bound Brook, NJ) JFC Technologies, LLC ("JFC"), a researcher, developer and manufacturer of pharmaceutical ingredients and applied materials, announced that it will sell its Chinese subsidiary JFC Technologies, Ningbo in the formation of Amerigen Pharmaceuticals, Inc - a private equity backed venture focused on making finished dose pharmaceuticals for Western Markets. As part of the transaction, JFC Technologies will receive stock in Amerigen as well as a 5 year consulting contract to assist at the Board level in the management of Amerigen. .
The Ningbo facility is specifically built to be compliant with ICH Q7A guidelines for manufacturing of bulk APIs. The design of the Ningbo facility allows for flexibility in producing various, commercial-scale API products. The primary production area consists of isolated production suites with separate air handling and extended temperature capabilities for handling a wide variety of chemistries. The reaction equipment ranges in scale from 2,000 to 5,000 liters.
Contacts: James G. Schleck, President and CEO. (732) 469-7760 Ext. 13